A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.

You are being sent to the original publisher. FX Radar keeps this reference for market context and source discovery.